Close Menu

NEW YORK ( GenomeWeb) – Danaher reported today a 4 percent year over year  increase in total revenues paced by a 10 percent jump in the Life Sciences business.

For the three months ending March 29, total revenues were $4.88 billion compared to $4.70 billion in the year-ago period. It beat the analysts' average estimate of $4.79 billion.

Core revenue growth was 5.5 percent year over year. M&A added 2.5 percent to growth while currency effects decreased revenues by 4 percent, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.